A tissue engineering approach for prenatal closure of myelomeningocele with gelatin sponges incorporating basic fibroblast growth factor

Tissue Engineering - Part A

Volumn 16, Issue 5, 2010, Pages 1645-1655

  Watanabe, Miho ^a,b   Jo, Jun Ichiro ^c   Radu, Antonetta ^a   Kaneko, Michio ^b   Tabata, Yasuhiko ^c   Flake, Alan W ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; CELL CULTURE; FIBROBLASTS; ORGANIC ACIDS; PEPTIDES; TISSUE ENGINEERING;

AMNIOTIC FLUID; BASIC FIBROBLAST GROWTH FACTOR; CELLULAR INGROWTH; COLLAGEN TYPE I; CYANOACRYLATES; EPITHELIAL CELLS; EXTRACELLULAR MATRICES; FURTHER DEVELOPMENT; GELATIN HYDROGELS; GELATIN SPONGE; HISTOLOGICAL EXAMINATION; HYALURONIC ACIDS; NEOVASCULARIZATION; RAT MODEL; THERAPEUTIC POTENTIALS;

TISSUE;

RATTUS;

FIBROBLAST GROWTH FACTOR 2; GELATIN;

ANGIOGENESIS; ANIMAL; ARTICLE; CATTLE; CONGENITAL MALFORMATION; DISEASE MODEL; DRUG EFFECT; EPIDERMIS; FEMALE; FETUS; GROWTH, DEVELOPMENT AND AGING; MENINGOMYELOCELE; METHODOLOGY; NERVOUS SYSTEM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; SURGICAL SPONGE; TISSUE ENGINEERING;

ANIMALS; CATTLE; DISEASE MODELS, ANIMAL; EPIDERMIS; FEMALE; FETUS; FIBROBLAST GROWTH FACTOR 2; GELATIN; MENINGOMYELOCELE; NEOVASCULARIZATION, PHYSIOLOGIC; NERVOUS SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; SURGICAL SPONGES; TISSUE ENGINEERING;

EID: 77953818605     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0532     Document Type: Article

References (36)

1. Heffez, D.S., Aryanpur, J., Hutchins, G.M., and Freeman, J.M. The paralysis associated with myelomeningocele: clinical and experimental data implicating a preventable spinal cord injury. Neurosurgery 26, 987, 1990.
2. Sutton, L.N., Adzick, N.S., and Bilaniuk, L.T. Improvement in hindbrain herniation demonstrated by serial fetal magnetic resonance imaging following fetal surgery for myelo-meningocele. JAMA 282, 1826, 1999.
3. Tulipan, N., Sutton, L.N., Bruner, J.P., Cohen, B.M., Johnson, M., and Adzick, N.S. The effect of intrauterine myelome-ningocele repair on the incidence of shunt-dependent hy-drocephalus. Pediatr Neurosurg 38, 27, 2003.
4. Johnson, M.P., Sutton, L.N., Rintoul, N., Crombleholme, T.M., Flake, A.W., Howell, L.J., Hedrick, H.L., Wilson, D.W., and Adzick, N.S. Fetal myelomeningocele repair: short-term clinical outcomes. Am J Obstet Gynecol 189, 482, 2003.
5. Johnson, M.P., Gerdes, M., Rintoul, N., Pasquariello, P., Melshionni, J., Sutton, L.N., and Adzick, N.S. Maternal-fetal surgery for myelomeningocele: neurodevelopmental outcomes at 2 years of age. Am J Obstet Gynecol 194, 1145, 2006.
6. Fichter, M.A., Dornseifer, U., Henke, J., Schneider, K.T., Kovacs, L., Biemer, E., Bruner, J., Adzick, N.S., Harrison, M.R., and Papadopulos, N.A. Fetal spina bifida repair-current trends and prospects of intrauterine neurosurgery. Fetal Diagn Ther 23, 271, 2008.
7. Sutton, L.N. Fetal surgery for neural tube defects. Best Pract Res Clin Obstet Gynaecol 22, 175, 2008.
8. Danzer, E., Adzick, N.S., Rintoul, N.E., Zarnow, D.M., Schwartz, E.S., Melchionni, J., Ernst, L.M., Flake, A.W., Sutton, L.N., and Johnson, M.P. Intradural inclusion cysts following in utero closure of myelomeningocele: clinical implications and follow-up findings. J Neurosurg Pediatr 2, 406, 2008.
9. Danzer, E., Gerdes, M., Bebbington, M.W., Sutton, L.N., Melchionni, J., Adzick, N.S., Wilson, R.D., and Johnson, M.P. Lower extremity neuromotor function and short-term ambulatory potential following in utero myelomeningocele surgery. Fetal Diagn Ther 25, 47, 2009.
10. Sanchez, R., Valente, P.R., Abou-Jamra, R.C., Araujo, A., Saldiva, P.H., and Pedreira, D.A.L. Biosynthetic cellulose induces the formation of a neoduramater following prenatal correction of meningocele in fetal sheep. Acta Cirurgica Brastletra 22, 174, 2007.
11. Kohl, T., Hartlage, M.G., Kiehitz, D., Westphal, M., Buller, T., Achenbach, S., Aryee, S., Gembruch, U., and Brentrup, A. Percutaneous fetoscopic patch coverage of experimental lumbosacral full-thickness skin lesions in sheep. Surg Endosc 17, 1218, 2003.
12. Eggink, A.J., Roelofs, L.A.J., Feitz, W.F.J., Wijnen, R.M.H., Mullaart, R.A., Grotenhuis, J.A., van Kuppevelt, T.H., Lammens, M.M.Y., Crevels, A.J., Hanssen, A., and van den Berg, P.P. In utero repair of an experimental neural tube defect in a chronic sheep model using biomatrices. Fetal Diagn Ther 20, 335, 2005.
13. Fauza, D.O., Fishman, J., Mehegan, K., and Atala, A. Vi-deofetoscopically assisted fetal tissue engineering; skin replacement. J Pediatr Surg 33, 357, 1998.
14. Danzer, E., Schwarz, U., Wehrli, S., Radu, A., Adzick, N.S., and Flake, A.W. Retinoic acid induced myelomeningocele in fetal rats: characterization by histopathological analysis and magnetic resonance imaging. Exp Neurol 194, 467, 2005.
15. Ozeki, M., and Tabata, Y. In vivo degradability of hydrogels prepared from different gelatins by various cross-linking methods. J Biomater Sci Polym Ed 16, 549, 2005.
16. Takahashi, Y., Yamamoto, M., and Tabata, Y. Osteogenic differentiation of mesenchymal stem cells in biodegradable sponges composed of gelatin and b-tricalcium phosphate. Biomaterials 26, 3587, 2005.
17. Kitano, Y., Yang, E.Y., Allmen, D.V., Quinn, T.M., Adzick, N.S., and Flake, A.W. Tracheal occlusion in the fetal rat: a new experimental model for the study of accelerated lung growth. J Pediatr Surg 33, 1741, 1998.
18. Borges, J., Mueller, M.C., Padron, N.T., Tegtmeier, F., Lang, E.M., and Stark, G.B. Engineered adipose tissue supplied by functional microvessels. Tissue Eng 9, 1263, 2003.
19. Day, R.M., Boccaccini, A.R., Shurey, S., Roether, J.A., Forbes, A., Hench, L.L., and Gabe, S.M. Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds. Biomaterials 25, 5857, 2004.
20. Danzer, E., Radu, A., Robinson, L.E., Volpe, M.V., Adzick, N.S., and Flake, A.W. Morphologic analysis of the neuro-muscular development of the anorectal unit in fetal rats with retinoic acid induced myelomeningocele. Neurosci Lett 430, 157, 2008.
21. Danzer, E., Kiddoo, D.A., Redden, R.A., Robinson, L., Radu, A., Zderic, S.A., Doolin, E.J., Adzick, N.S., and Flake A.W. Structural and functional characterization of bladder smooth muscle in fetal rats with retinoic acid-induced myelome-ningocele. Am J Physiol Renal Physiol 292, 197, 2006.
22. Tabata, Y., Nagano, A., and Ikada, Y. Biodegradation of hydrogel carrier incorporating fibroblast growth factor. Tissue Eng 5, 127, 1999.
23. Tabata, Y., and Ikada, Y. Vascularization effect of basic fi-broblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials 20, 2169, 1999.
24. Ozeki, M., and Tabata, Y. In vivo degradability of hydrogels prepared from different gelatins by various cross-linking methods. J Biomater Sci Polym Ed 16, 549, 2005.
25. Miyoshi, M., Kawazoe, T., Igawa, H.H., Tabata, Y., Ikada, Y., and Suzuki, S. Effects of bFGF incorporated into a gelatin sheet on wound healing. J Biomater Sci Polym Ed 16, 893, 2005.
26. Tsuji-Saso, Y., Kawazoe, T., Morimoto, N., Tabata, Y., Taira, T., Tomihata, K., Utani, A., and Suzuki, S. Incorporation of basic fibroblast growth factor into preconfluent cultured skin substitute to accelerate neovascularization and skin reconstruction after transplantation. Scand J Plast Reconstr Surg Hand Surg 41, 228, 2007.
27. Kawai, K., Suzuki, S., Tabata, Y., and Nishimura, Y. Accelerated wound healing through the incorporation of basic fibroblast growth factor-impregnated gelatin micro-spheres into artificial dermis using a pressure-induced decubitus ulcer model in genetically diabetic mice. Br J Plast Surg 58, 1115, 2005.
28. Tabata, Y. Biomaterial technology for tissue engineering applications. J R Soc Interface 6, 311, 2009.
29. Hashimoto, T., Koyama, H., Miyata, T., Hosaka, A., Tabata, Y., Takato, T., and Nagawa, H. Selective and sustained delivery of basic fibroblast growth factor for treatment of peripheral arterial disease: results of a phase I trial. Eur J Vasc Endovasc Surg 38, 71, 2009.
30. Esaki, J., Marui, A., Tabata, Y., and Komeda, M. Controlled release systems of angiogenic growth factors for cardiovascular disease. Expert Opin Drug Deliv 4, 635, 2007.
31. Gremlich, S., Nquyen, D., Reymondin, D., Hohlfeld, P., Vial, Y., Witkin, S.S., and Gerber, S. Fetal MMP2=MMP9 polymorphisms and intrauterine growth restriction risk. J Reprod Immunol 74, 143, 2007.
32. Peltier, M.R., Barney, B.M., and Brown, M.B. Effect of experimental genital mycoplasmosis on production of matrix metalloproteinases in membranes and amniotic fluid of Sprague-Dawley rats. Am J Reprod Immunol 57, 116, 2007.
33. Bullard, K.M., Longaker, M.T., and Lorenz, H.P. Fetal wound healing: current biology. World J Surg 27, 54, 2003.
34. Longaker, M.T., Chiu, E.S., Adzick, N.S., Stern, M., Harrison, M.R., and Stern, R. Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid. Ann Surg 213, 292, 1991.
35. Tabata, Y., Hijikata, S., Muniruzzaman, M.D., and Ikada, Y. Neovascularization effect of biodegradable gelatin micro-spheres incorporating basic fibroblast growth factor. J Bio-mater Sci Polym Ed 10, 79, 1999.
36. Tabata, Y. Regenerative inductive therapy based on DDS technology of protein and gene. J Drug Target 14, 483, 2006.